GoodRx announced a new e-commerce solution starting with over-the-counter birth control pill Opill. It also is offering new affordability programs for menopause medications with Pfizer. The post GoodRx Expands Women’s Health Options with New Birth Control and Menopause Offerings appeared first on MedCity News.
In this month’s episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that occurred recently in the healthcare sector. She also interviewed Claire Zangerle, who was appointed as chief nurse executive of the American Hospital Association, as well as CEO of its American Organization for Nursing Leadership. The post MedCity…
SACRAMENTO — Gov. Gavin Newsom on Wednesday proposed that California roll back health care for immigrants without legal status, saying the state needed to cut benefits for some to maintain core services across the board. It’s a striking reversal for the Democrat, who had promised universal health care and called health coverage for immigrants the…
Let’s say you’re the CEO of a health plan. A new drug just received approval to treat patients with lung cancer. The drug’s clinical trial examined how well the the drug worked on third line (3L) patients and patients with good funcional ability (e.g., performance status ECOG score of 0 or 1). FDA approved the…
Nonprofit population health services company starts with internal customers but plans to expand
Voters in three states — Arizona, Missouri, and Nevada — chose on Tuesday to advance protections for abortion rights in their state constitutions. Donald Trump, meanwhile, is likely to win all three states in his victorious bid for the White House. It’s a conundrum for Democrats, who expected ballot initiatives on abortion rights in those…
Gilead Sciences is acquiring Ouro Medicines, a startup developing T cell engagers for a range of autoimmune diseases. Separately, Gilead is negotiating a deal with Galapagos to share in the development and potential commercialization of the Ouro drug. The post Gilead Sciences Gains an Opportunity for Immune System Reset With $1.7B Ouro Acquisition appeared first…
In the past, patient comfort often came at the cost of medical testing. However, the future of sleep monitoring doesn’t have to forgo either, with radar monitoring systems allowing for both a comfortable testing environment and a more accurate reading of sleep health. The post Redefining Sleep Health: From PSG Limitations to Next-Generation Solutions appeared…
That is a key question if long-run drug prices are going to come down for biologic products. We can decompose this question into 3 sub-questions: What share patients initiating therapy start on a biosimilar?What share of patients already using a biologic products switch to a biosimilar?Do patient of physician factors drive biosimilar prescribing patterns? A…
Healthtech companies have to navigate a maze of complex regulations, prove their financial model, and win over multiple stakeholders. Finding the right balance between patient protection and innovation is crucial. The post Barriers and Pathways to Healthtech Adoption in Clinical Practice appeared first on MedCity News.